Microdochectomy for Chronic Non Dilated Single Duct Nipple Discharge

NCT ID: NCT07305558

Last Updated: 2025-12-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-27

Study Completion Date

2026-04-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to evaluate the efficacy of a new technique in treatment of single milk duct discharge. The main questions it aims to answer are:

Does ultrasound guided microdochectomy is feasible in non dilated milk duct? What are the surgical outcomes of this technique?

Participants will:

Had ultrasound microdochectomy After discharge, patients will visit the clinic twice every week for two weeks, a visit or call after 3 month

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nipple Discharge

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

nipple discharge microdochectomy breast

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients with single milk duct discharge

Group Type EXPERIMENTAL

ultrasound guided microdochectomy

Intervention Type PROCEDURE

ultrasound was used to perform microdochectomy for single not dilated milk duct without cannulation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ultrasound guided microdochectomy

ultrasound was used to perform microdochectomy for single not dilated milk duct without cannulation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* females above 18 years old with single not dilated milk duct discharge after failure of medical treatment

Exclusion Criteria

* breast cancer
* patients with multiple or dilated milk duct discharge.
* contraindications to surgery or ‬anaesthesia
* patient above 18 years old
* patients refuse to participate in the study
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zagazig University

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Reham Zakaria Mohamed Ahmed

lecturer of general surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Reham Zakaria, M.D

Role: PRINCIPAL_INVESTIGATOR

faculty of medicine, Zagazig University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

faculty of medicine, Zagazig University

Zagazig, Zagazig, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1248\27-4-2025

Identifier Type: -

Identifier Source: org_study_id